SVP at Emergent BioSolutions (NYSE: EBS) receives 100,111 RSUs
Rhea-AI Filing Summary
Hartzel William reported acquisition or exercise transactions in this Form 4 filing.
Emergent BioSolutions Inc. granted Senior Vice President of Bioservices William Hartzel 100,111 shares of Common Stock in the form of restricted stock units. The award was approved by the Compensation Committee on March 2, 2026, contingent on stockholder approval of an amended stock incentive plan.
Stockholders approved the Amended Stock Incentive Plan on April 29, 2026, allowing the grant to proceed. These restricted stock units vest in three annual installments beginning on the anniversary of the approval date, assuming continued service. After this grant, Hartzel directly holds 187,299 shares of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 100,111 shares
Net Buy
1 txn
Insider
Hartzel William
Role
SVP, Bioservices
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 100,111 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 187,299 shares (Direct)
Footnotes (2)
- F1. The restricted stock unit grant was approved by the Compensation Committee of Emergent BioSolutions Inc. (the "Company"), on March 2, 2026, subject to stockholder approval of an amendment of the Company's 2006 Stock Incentive Plan (the "Amended Stock Incentive Plan"), under which the restricted stock units were granted. The Company's stockholders approved the Amended Stock Incentive Plan on April 29, 2026.
- F2. Consists of restricted stock units granted under the Company's Amended Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the anniversary of the date of approval, assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
Key Figures
RSUs granted: 100,111 restricted stock units
Grant price per share: $0.0000 per share
Total shares after grant: 187,299 shares
+2 more
5 metrics
RSUs granted
100,111 restricted stock units
Grant of common stock RSUs to SVP, Bioservices
Grant price per share
$0.0000 per share
Reported transaction price for the RSU award
Total shares after grant
187,299 shares
Direct holdings following the RSU grant
Stockholder approval date
April 29, 2026
Approval of Amended Stock Incentive Plan enabling the grant
Committee approval date
March 2, 2026
Compensation Committee approval of RSU grant, subject to stockholder vote
Key Terms
restricted stock units, Amended Stock Incentive Plan, Compensation Committee
3 terms
restricted stock units financial
"Consists of restricted stock units granted under the Company's Amended Stock Incentive Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Amended Stock Incentive Plan financial
"subject to stockholder approval of an amendment of the Company's 2006 Stock Incentive Plan (the "Amended Stock Incentive Plan")"
Compensation Committee financial
"The restricted stock unit grant was approved by the Compensation Committee of Emergent BioSolutions Inc."
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Emergent BioSolutions (EBS) disclose in this Form 4 for William Hartzel?
Emergent BioSolutions reported that SVP, Bioservices, William Hartzel received a grant of 100,111 restricted stock units of common stock. The award increases his direct holdings to 187,299 shares, reflecting equity-based compensation rather than an open-market stock purchase or sale.
What is William Hartzel’s total Emergent BioSolutions (EBS) ownership after this Form 4 transaction?
Following the restricted stock unit grant, William Hartzel directly holds 187,299 shares of Emergent BioSolutions common stock. This figure includes the newly awarded 100,111 restricted stock units and represents his total direct beneficial ownership after the reported transaction.
How do the restricted stock units granted to William Hartzel vest at Emergent BioSolutions (EBS)?
The restricted stock units granted to William Hartzel vest in three annual installments, starting on the anniversary of the approval date. Vesting requires his continued service with Emergent BioSolutions, aligning the compensation structure with longer-term employment and performance incentives.
What approvals were required for William Hartzel’s restricted stock unit grant at Emergent BioSolutions (EBS)?
The grant was approved by the company’s Compensation Committee on March 2, 2026, but was contingent on stockholder approval of the Amended Stock Incentive Plan. Stockholders approved this amended plan on April 29, 2026, enabling the restricted stock unit award.
Are William Hartzel’s restricted stock units at Emergent BioSolutions (EBS) tied to the Amended Stock Incentive Plan?
Yes. The restricted stock units were granted under Emergent BioSolutions’ Amended Stock Incentive Plan. The award became effective after stockholders approved the amended plan, and each unit entitles him to receive one share of common stock upon vesting, subject to grant agreement terms.